VEGFA and myocardial infarction: The initial in vitro evaluation of clinically approved SPION formulation (ferumoxytol) functionalized with vascular endothelial growth factor (VEGF) for potential future use in patients with myocardial infarction showed their positive effect on cell survival and growth (Bietenbeck et al., 2019).